• 1. Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Department of Ultrasound, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
LI Kewei, Email: vivian5225133@outlook.com
Export PDF Favorites Scan Get Citation

Objective To summarize the treatment and experience of percutaneous transhepatic portal vein recanalization by endovascular approach for treatment of cavernous transformation of the portal vein (CTPV) in a child. Method The clinical data of a child with idiopathic CTPV who underwent percutaneous transhepatic portal vein recanalization by endovascular approach were retrospectively analyzed. Results We described a novel percutaneous transhepatic portal vein recanalization approach that had successfully treated a child with idiopathic CTPV following a multidisciplinary team evaluation. The operation time was 1.5 h and blood loss was approximately 1 mL. The child recovered uneventfully at 9-month follow-up, without any clinical evidence of CTPV complications. Conclusion In light of our successful management, we can envision that the portal vein recanalization is an important therapeutic supplement for treating CTPV and will result in a paradigm change.

Citation: WEI Bo, WU Hao, ZHANG Jingyi, XIE Xiaolong, XIANG Bo, LI Kewei. Successful management of cavernous transformation of portal vein in a child using percutaneous transhepatic portal vein recanalization by endovascular approach. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(4): 397-402. doi: 10.7507/1007-9424.202302050 Copy

  • Previous Article

    Analysis of targeted therapy combined with immunotherapy for hepatocellular carcinoma
  • Next Article

    Study on guidelines of Chinese Society of Clinical Oncology (CSCO): hepatocellular carcinoma (2022)